Open to opportunities

Maha Obeid Chauveau

@mahaobeidchauveau

Senior pharmaceutical commercial leader and General Manager driving European/global launches and inclusive, patient-centric growth.

France

Message

What I'm looking for

I’m looking for a leadership role where I can drive inclusive, patient-centric commercialization—owning P&L, shaping brand and portfolio strategy, and partnering cross-functionally to accelerate regulated launches with strong market access, HTA, and digital engagement.

I’m a senior pharmaceutical and biotech commercial leader with 20+ years of inclusive leadership, focused on driving European and global commercial launches in regulated, patient-centric environments. I’m known for translating complex clinical data into clear, actionable commercial strategies and building teams that deliver sustainable results.

Most recently, as a Country Manager with full P&L ownership, I established and led the French affiliate and accelerated market entry through digital and omnichannel solutions—strengthening HCP engagement and brand adoption. Before that, as a Business Unit Director (Ophtalmology), I restructured and integrated high-performing teams, delivered sustained >8% year-over-year growth, and drove end-to-end portfolio strategy across innovative injectable ophthalmology products.

Earlier in my career, I led large-scale commercialization across multi-market portfolios—accelerating Rinvoq’s launch by 18 months, embedding regional insights into global launch strategy, and advancing pricing and access outcomes. Whether in immunology, rheumatology, oncology, or digital engagement, I bring cross-functional leadership, HTA and reimbursement support expertise, and matrix management to turn evidence into value and execution excellence.

Experience

Work history, roles, and key accomplishments

Current

Country Manager

Current

Republic M

Sep 2024 - Present (1 year 9 months)

Established and led the French affiliate with full P&L ownership, improving operational and financial performance while building a sustainable local organization. Drove market entry through digital and omnichannel solutions, strengthening HCP engagement and brand adoption.

P&L management Market Entry Strategy Client Partnership Management Business Development operational performance

Business Unit Director

AbbVie

May 2021 - Feb 2024 (2 years 9 months)

Integrated, restructured, and led high-performing teams, strengthening talent capabilities and execution excellence. Owned end-to-end ophthalmology portfolio strategy and delivered sustained 8%+ YoY growth by advancing differentiated brand positioning across lifecycle and innovation segments.

Portfolio Strategy P&L management Compliance & Ethics Brand Strategy Lifecycle Management Cross Functional Execution

Area Commercial Director

AbbVie

Jan 2018 - May 2021 (3 years 4 months)

Accelerated the Rinvoq (JAK inhibitor) launch by 18 months through strong cross-functional and affiliate execution. Led regional commercialization and launch readiness across 15 markets, optimizing market entry, pricing, and access outcomes and embedding regional insights into global strategy.

Launch Acceleration Pricing Strategy Regionalization Affiliate Capability Building Cross functional Coordination

Rheumatology Business Unit Manager

AbbVie

Jan 2016 - Dec 2017 (1 year 11 months)

Owned and executed commercial strategy for Humira rheumatology indications while navigating competitive markets and payer dynamics. Delivered 10% YoY growth by defending market leadership through payer engagement and evidence-based value positioning.

Commercial Strategy Market Leadership Payer Engagement Evidence Based Value Positioning

Biotherapeutics Director

AbbVie

Jan 2015 - Jan 2016 (1 year)

Led biosimilar market entry readiness, including commercial strategy, stakeholder education, and organizational preparation. Partnered with global teams to align scientific messaging and regional launch frameworks.

Principal and Head of MENA

Whiteshield

Jan 2012 - Dec 2014 (2 years 11 months)

Led business development in the MENA region as Principal and Head, screening sectors with high economic impact and running due diligence to select target companies. Enabled EBRD investment of over €400M across multiple healthcare and other projects in the region.

Business Development Due Diligence Investment Advisory

Marketing Director

Sandoz

Jan 2009 - Dec 2011 (2 years 11 months)

Directed oncology–endocrinology marketing activities for a €20M portfolio, coordinating stakeholder engagement and cross-functional execution. Supported go-to-market planning with an emphasis on KOL and healthcare partner relationships.

Marketing Strategy Portfolio Management Go To Market Planning KOL Engagement Stakeholder Management Cross Functional Execution